Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbon Monoxide | 8 | 2021 | 531 | 3.620 |
Why?
|
| Cardiopulmonary Resuscitation | 5 | 2020 | 980 | 1.660 |
Why?
|
| Microcirculation | 10 | 2023 | 1286 | 1.610 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 4 | 2019 | 33 | 1.490 |
Why?
|
| Heart Arrest | 4 | 2020 | 1470 | 1.350 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2020 | 1354 | 1.270 |
Why?
|
| Critical Illness | 12 | 2023 | 2670 | 0.980 |
Why?
|
| Carboxyhemoglobin | 2 | 2019 | 81 | 0.810 |
Why?
|
| Capillary Leak Syndrome | 2 | 2019 | 31 | 0.770 |
Why?
|
| Atrial Flutter | 1 | 2022 | 263 | 0.720 |
Why?
|
| Extracorporeal Circulation | 1 | 2019 | 182 | 0.670 |
Why?
|
| Protective Agents | 1 | 2019 | 156 | 0.630 |
Why?
|
| Critical Care | 6 | 2022 | 2647 | 0.610 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2022 | 591 | 0.590 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2018 | 243 | 0.590 |
Why?
|
| Mouth Mucosa | 1 | 2020 | 434 | 0.580 |
Why?
|
| Capillary Permeability | 2 | 2019 | 798 | 0.530 |
Why?
|
| Evoked Potentials, Motor | 1 | 2018 | 454 | 0.530 |
Why?
|
| Hemodynamics | 4 | 2020 | 4199 | 0.520 |
Why?
|
| Hydrogen Sulfide | 3 | 2022 | 137 | 0.500 |
Why?
|
| Drug Carriers | 1 | 2019 | 693 | 0.490 |
Why?
|
| Anesthetics | 1 | 2019 | 539 | 0.450 |
Why?
|
| Swine | 6 | 2020 | 5917 | 0.430 |
Why?
|
| Intensive Care Units | 11 | 2023 | 3679 | 0.430 |
Why?
|
| Rolipram | 3 | 2019 | 27 | 0.400 |
Why?
|
| Sepsis | 5 | 2022 | 2593 | 0.400 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 1637 | 0.380 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2022 | 3537 | 0.370 |
Why?
|
| Terminal Care | 1 | 2022 | 1694 | 0.360 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 1199 | 0.340 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2149 | 0.320 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3670 | 0.290 |
Why?
|
| Endothelium, Vascular | 2 | 2017 | 4456 | 0.290 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 5034 | 0.280 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3589 | 0.270 |
Why?
|
| Reperfusion Injury | 2 | 2022 | 1026 | 0.250 |
Why?
|
| Inflammation | 5 | 2021 | 10638 | 0.230 |
Why?
|
| Acute Kidney Injury | 3 | 2023 | 1972 | 0.230 |
Why?
|
| Tricuspid Valve | 2 | 2023 | 403 | 0.220 |
Why?
|
| Microscopy, Video | 2 | 2020 | 245 | 0.220 |
Why?
|
| Animals | 19 | 2022 | 168757 | 0.200 |
Why?
|
| History, 15th Century | 1 | 2021 | 31 | 0.200 |
Why?
|
| History, Medieval | 1 | 2021 | 63 | 0.200 |
Why?
|
| History, 16th Century | 1 | 2021 | 72 | 0.200 |
Why?
|
| History, 17th Century | 1 | 2021 | 111 | 0.190 |
Why?
|
| Europe | 3 | 2022 | 3339 | 0.190 |
Why?
|
| Heart Failure | 2 | 2022 | 10900 | 0.190 |
Why?
|
| History, Ancient | 1 | 2021 | 212 | 0.190 |
Why?
|
| History, 18th Century | 1 | 2021 | 214 | 0.190 |
Why?
|
| Prospective Studies | 14 | 2024 | 53288 | 0.190 |
Why?
|
| Mouth Floor | 1 | 2020 | 34 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2022 | 8301 | 0.180 |
Why?
|
| Peritonitis | 1 | 2022 | 365 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 349 | 0.170 |
Why?
|
| Frail Elderly | 2 | 2021 | 693 | 0.170 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2019 | 42 | 0.170 |
Why?
|
| Oximetry | 2 | 2023 | 471 | 0.170 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2020 | 122 | 0.160 |
Why?
|
| Forelimb | 1 | 2018 | 122 | 0.160 |
Why?
|
| History, 19th Century | 1 | 2021 | 720 | 0.160 |
Why?
|
| Resuscitation | 2 | 2023 | 658 | 0.160 |
Why?
|
| Sus scrofa | 1 | 2020 | 437 | 0.160 |
Why?
|
| Second Messenger Systems | 1 | 2019 | 206 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2021 | 401 | 0.160 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 18029 | 0.160 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 721 | 0.150 |
Why?
|
| Humans | 35 | 2024 | 744343 | 0.150 |
Why?
|
| Rats | 9 | 2022 | 24260 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 684 | 0.150 |
Why?
|
| Cyclic AMP | 2 | 2019 | 1472 | 0.140 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 383 | 0.140 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 1082 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 381 | 0.140 |
Why?
|
| Hindlimb | 1 | 2018 | 504 | 0.140 |
Why?
|
| Shock, Septic | 1 | 2023 | 775 | 0.140 |
Why?
|
| Cardiac Output | 1 | 2019 | 854 | 0.140 |
Why?
|
| Myenteric Plexus | 1 | 2016 | 39 | 0.140 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2022 | 1133 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2023 | 832 | 0.130 |
Why?
|
| Respiration, Artificial | 3 | 2022 | 2569 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2021 | 1534 | 0.130 |
Why?
|
| Low Back Pain | 1 | 2023 | 956 | 0.130 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 924 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1518 | 0.120 |
Why?
|
| Retina | 2 | 2022 | 2616 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2023 | 2731 | 0.120 |
Why?
|
| Brain | 1 | 2020 | 26385 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2021 | 2740 | 0.110 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 1536 | 0.110 |
Why?
|
| Delirium | 1 | 2024 | 1609 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2018 | 957 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2171 | 0.100 |
Why?
|
| Endothelium | 1 | 2014 | 778 | 0.100 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 57776 | 0.100 |
Why?
|
| Fluid Therapy | 1 | 2015 | 593 | 0.100 |
Why?
|
| Vascular Diseases | 2 | 2017 | 1161 | 0.100 |
Why?
|
| Cytokines | 3 | 2023 | 7322 | 0.100 |
Why?
|
| Neuroglia | 1 | 2016 | 927 | 0.090 |
Why?
|
| Aged | 11 | 2024 | 163280 | 0.090 |
Why?
|
| Male | 17 | 2022 | 350118 | 0.090 |
Why?
|
| Bacteria | 1 | 2020 | 2114 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2020 | 2925 | 0.090 |
Why?
|
| Aminopyridines | 1 | 2012 | 542 | 0.080 |
Why?
|
| Pandemics | 3 | 2022 | 8388 | 0.080 |
Why?
|
| Apoptosis | 2 | 2021 | 9727 | 0.070 |
Why?
|
| Prognosis | 4 | 2022 | 29063 | 0.070 |
Why?
|
| Benzamides | 1 | 2012 | 1379 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2019 | 4397 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2015 | 1139 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2015 | 2119 | 0.060 |
Why?
|
| Time Factors | 3 | 2021 | 40075 | 0.060 |
Why?
|
| Rome | 1 | 2023 | 28 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 3240 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14722 | 0.060 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2023 | 76 | 0.060 |
Why?
|
| Lipopolysaccharides | 3 | 2016 | 2216 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2023 | 63114 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2023 | 77449 | 0.050 |
Why?
|
| Neurons | 1 | 2021 | 9338 | 0.050 |
Why?
|
| Diskectomy | 1 | 2023 | 206 | 0.050 |
Why?
|
| Risk Factors | 3 | 2024 | 72290 | 0.050 |
Why?
|
| Female | 9 | 2022 | 380194 | 0.050 |
Why?
|
| Quality of Life | 1 | 2022 | 12804 | 0.050 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2020 | 122 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 13881 | 0.040 |
Why?
|
| Perfusion | 1 | 2023 | 1360 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2021 | 10252 | 0.040 |
Why?
|
| Symbiosis | 1 | 2020 | 287 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23403 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2024 | 15295 | 0.030 |
Why?
|
| Steroids | 1 | 2021 | 930 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 10943 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2021 | 770 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2015 | 191 | 0.030 |
Why?
|
| Colloids | 1 | 2015 | 136 | 0.030 |
Why?
|
| Random Allocation | 1 | 2020 | 2429 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2024 | 1177 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 941 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 528 | 0.030 |
Why?
|
| Lipocalins | 1 | 2015 | 170 | 0.030 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 133 | 0.030 |
Why?
|
| Cystatin C | 1 | 2015 | 250 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 262 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2023 | 1848 | 0.030 |
Why?
|
| Colon | 1 | 2022 | 1772 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2015 | 416 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 4933 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 450 | 0.030 |
Why?
|
| Ischemia | 1 | 2022 | 1907 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 1420 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2021 | 2499 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 2418 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 3508 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2012 | 416 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2214 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2021 | 8436 | 0.020 |
Why?
|
| Stents | 1 | 2022 | 3280 | 0.020 |
Why?
|
| Creatinine | 1 | 2015 | 1919 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 19905 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2022 | 5007 | 0.020 |
Why?
|
| Capillaries | 1 | 2012 | 773 | 0.020 |
Why?
|
| Pain | 1 | 2024 | 4986 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6309 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2021 | 6442 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2015 | 3002 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9146 | 0.020 |
Why?
|
| Acute Disease | 1 | 2016 | 7149 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 5882 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 9959 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4554 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10262 | 0.010 |
Why?
|
| Cell Line | 1 | 2015 | 15997 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9438 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 40561 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 214055 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 81183 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 213383 | 0.000 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_